MedTrace Logo

Clinical Evaluation of the RH210 Hearing Aid

NCT07572357 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2026-05-29

No results posted yet for this study

Summary

The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.

Conditions

  • Hearing Impairment, Sensorineural
  • Perceived Hearing Loss

Interventions

DEVICE

Investigational device (RH210A)

Over the counter device

DEVICE

Apple AirPods Pro (2nd Generation) with Hearing Aid Feature (HAF)

FDA cleared OTC device (Control arm)

Sponsors & Collaborators

  • Global Edge Medtech Consulting

    collaborator UNKNOWN

  • National Acoustic Laboratories

    collaborator UNKNOWN

  • Rehear Audiology Company LTD

    lead INDUSTRY

Principal Investigators

  • Bettina Turnbull, Doctor of Audiology · National Acoustic Laboratories

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-11
Primary Completion
2026-07-30
Completion
2026-08-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07572357 on ClinicalTrials.gov